Efforts to develop COVID-19 vaccines are well underway, and protecting the scientific integrity of the process is paramount. The trials must be—and must be seen to be—free of political interference, carried out with the highest scientific and ethical rigor, and allowed to proceed until the safety and efficacy of each candidate vaccine has been thoroughly assessed. The ultimate goal is global distribution of and equitable access to effective vaccines that can help slow, and eventually end, the pandemic.

Johns Hopkins University and the University of Washington are bringing together leading experts to explore these issues and put forward a concise plan for protecting the scientific integrity of these lifesaving efforts. “Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation” will feature insights from global leaders in vaccine science, health metrics, policy, regulation, and communications.

Confirmed speakers include Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases; Dr. Francis Collins, director of the National Institutes of Health; Michael Bloomberg, former mayor of New York City and founder of Bloomberg Philanthropies; Dr. Christopher Murray, director of the UW’s Institute for Health Metrics and Evaluation; Dr. Keith Jerome, director of the UW Virology Laboratory and professor in UW Medicine’s Department of Laboratory Medicine and Pathology; Dr. Larry Corey, professor in UW Medicine’s Department of Laboratory Medicine and Pathology; and Dr. Michele Andrasik, affiliate assistant professor in the UW’s departments of Global Health and Environmental & Occupational Health Sciences.

Register now to better understand the current process and what’s needed to safely develop and launch COVID-19 vaccines.